HONGKONG, CHINA--(Marketwired - Nov 23, 2016) - Hutchison China Meditech Limited (NASDAQ: HCM)
Director's Share Dealing
London: Wednesday, November 23, 2016: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notification that Mr Michael Howell, Independent Non-executive Director, sold 10,000 ordinary shares of US$1.00 each in Chi-Med (the "Ordinary Shares") at an average price of GBP18.83 per share on November 18, 2016 and November 21, 2016 under a personal share trading plan (the "Plan"). Pursuant to the Plan, a total of 20,000 Ordinary Shares have now been sold. Previously under the Plan 10,000 Ordinary Shares were sold between October 24, 2016 and October 28, 2016 and announced on November 1, 2016. The Plan was put in place by Mr Howell to facilitate a financial settlement arising from a marital separation agreement.
Following the above sale of 10,000 Ordinary Shares, the holding of Mr Howell is 118,600 Ordinary Shares, representing approximately 0.20% of the current issued share capital of Chi-Med.
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
Last updated on: 29/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.